LSV Asset Management
PDLI

LSV Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

LSV Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-77,100
Closed -$190K – 1038
2017
Q2 		$190K Hold
77,100
– – ﹤0.01% 943
2017
Q1 		$175K Hold
77,100
– – ﹤0.01% 963
2016
Q4 		$163K Hold
77,100
– – ﹤0.01% 939
2016
Q3 		$258K Buy
77,100
+67,700
+720% +$215K ﹤0.01% 906
2016
Q2 		$29K Sell
9,400
-907,600
-99% -$3.03M ﹤0.01% 1077
2016
Q1 		$3.05M Sell
917,000
-327,800
-26% -$1.02M 0.01% 594
2015
Q4 		$4.41M Sell
1,244,800
-112,000
-8% -$469K 0.01% 520
2015
Q3 		$6.82M Hold
1,356,800
– – 0.02% 453
2015
Q2 		$8.72M Sell
1,356,800
-338,683
-20% -$2.27M 0.02% 405
2015
Q1 		$11.9M Sell
1,695,483
-100,400
-6% -$727K 0.02% 339
2014
Q4 		$13.8M Sell
1,795,883
-8,900
-0.5% -$70.4K 0.03% 320
2014
Q3 		$13.5M Sell
1,804,783
-145,200
-7% -$1.35M 0.03% 309
2014
Q2 		$18.9M Sell
1,949,983
-22,100
-1% -$197K 0.04% 274
2014
Q1 		$16.4M Sell
1,972,083
-52,000
-3% -$446K 0.04% 286
2013
Q4 		$17.1M Sell
2,024,083
-41,800
-2% -$352K 0.04% 281
2013
Q3 		$16.5M Buy
2,065,883
+10,583
+0.5% +$85.1K 0.04% 275
2013
Q2 		$15.9M Buy
+2,055,300
New +$16M 0.04% 274

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management's PDLI Position: Q3 2017 in Review

LSV Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2017, closing a stake of 77,100 shares — an estimated $190K sold.

LSV Asset Management first reported a position in PDLI in Q2 2013 and held it in 17 quarters. The position peaked at $18.9M in Q2 2014. 186 funds tracked by Wall St. Rank hold PDLI as of Q3 2017.

  • LSV Asset Management reported no remaining PDL BioPharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • LSV Asset Management sold 77,100 PDL BioPharma, Inc. shares in Q3 2017, an estimated $190K.
  • LSV Asset Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 17 quarters.
  • LSV Asset Management's PDL BioPharma, Inc. position peaked at $18.9M in Q2 2014.
  • 186 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2017.

Based on LSV Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.